Next Quarterly Earnings
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
CytomX Therapeutics is a U.S.-based biotechnology company specializing in the development of innovative cancer therapies. Through its proprietary Probody technology, the company enables precision-targeted oncology to spare healthy tissue while effectively combating tumors.
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
CytomX Therapeutics is scheduled to report its next quarterly earnings on 11/10/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
CytomX Therapeutics last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at -0.09 USD.
Across its last 3 earnings reports, CytomX Therapeutics stock moved by ±15.8% on average the following day. The largest reaction was +44.2% on 03/16/2026; 2 of 3 reactions were positive.
CytomX Therapeutics has beaten analyst EPS estimates in 2 of its last 5 evaluated quarters (beat rate: 40%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.